Download PDF
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2022; 09(02): 093-098
DOI: 10.1055/s-0042-1749656
Original Article

Association of ABO Blood Group Antigen and Neurological Tumors

Gopal K. Patidar
1   Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India
,
Yashaswi Dhiman 
2   Department of Immunohematology and Blood Transfusion, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India
,
Anjali Hazarika
1   Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Background Various risk factors for tumors such as smoking, alcohol consumption, diet, and radiation, etc., were already identified. ABO blood group antigens are also present on epithelia, endothelia, and neurons. Recent evidence suggested the role of ABO antigens in the pathogenesis of certain malignancies.

Materials and Methods A retrospective observational study was conducted in a tertiary care neurosurgical center in North India from January 2016 to December 2018. The hospital information system was used to obtain patient information while the blood center information system was used to collect blood group information. Brain tumors were majorly divided into cavernoma, glioma, meningioma, neuroma, pituitary adenoma, schwannoma, and others.

Results We found a total of 1,970 patients with brain tumors admitted during our study period. Most patients had glioma (33.55%), followed by pituitary adenoma (20.05%) and neuroma (2.23%). B blood group individuals had more prevalence of cavernoma, glioma, meningioma, pituitary adenoma, schwannoma, and others followed by O, A, and AB. Only association of O blood group with neuroma tumor was found statistically significant.

Conclusions Our patient population had blood group distribution similar to our general population and no significant association was observed by blood group antigens and brain tumors. Although neuroma was significantly associated with blood group O but the prevalence of neuroma in our patient population is very low hence large sample study is required to draw a firm conclusion regarding this association.

Keywords

blood groups - neurological tumors - association - neuroma


Publication History

Article published online:
20 July 2022

© 2022. Indian Society of Neuroanaesthesiology and Critical Care. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65 (02) 87-108
    CrossrefPubMedGoogle Scholar
  • 2 Anand P, Kunnumakkara AB, Sundaram C. et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008; 25 (09) 2097-2116
    CrossrefPubMedGoogle Scholar
  • 3 Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 2005; 23 (02) 276-292
    CrossrefPubMedGoogle Scholar
  • 4 Franchini M, Liumbruno GM. ABO blood group and neurodegenerative disorders: more than a casual association. Blood Transfus 2016; 14 (02) 158-159
    PubMedGoogle Scholar
  • 5 Zhang BL, He N, Huang YB, Song FJ, Chen KX. ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2014; 15 (11) 4643-4650
    CrossrefPubMedGoogle Scholar
  • 6 Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009; 25 (02) 48-59
    CrossrefPubMedGoogle Scholar
  • 7 Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998; 38 (10) 975-988
    CrossrefPubMedGoogle Scholar
  • 8 Li Q, Yu CH, Yu JH. et al. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. PLoS One 2012; 7 (01) e29928
    CrossrefPubMedGoogle Scholar
  • 9 Song HR, Shin MH, Kim HN. et al. Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population. Gastric Cancer 2013; 16 (02) 254-260
    CrossrefPubMedGoogle Scholar
  • 10 Rizzato C, Campa D, Pezzilli R. et al. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep 2013; 29 (04) 1637-1644
    CrossrefPubMedGoogle Scholar
  • 11 Wang Z, Liu L, Ji J. et al. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci 2012; 13 (10) 13308-13321
    CrossrefPubMedGoogle Scholar
  • 12 Poole EM, Gates MA, High BA. et al. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes Control 2012; 23 (11) 1805-1810
    CrossrefPubMedGoogle Scholar
  • 13 Nakao M, Matsuo K, Ito H. et al. ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection. Cancer Epidemiol Biomarkers Prev 2011; 20 (08) 1665-1672
    CrossrefPubMedGoogle Scholar
  • 14 Diamond LK, Levine RP, Mayr E, Mayr M. Suspected correlation between blood-group frequency and pituitary adenomas. Science 1956; 124 (3228): 932-934
    CrossrefPubMedGoogle Scholar
  • 15 Selverstone B, Cooper DR. Astrocytomas and ABO blood groups. J Neurosurg 1961; 18: 602-604
    CrossrefPubMedGoogle Scholar
  • 16 Sowbhagya P, Kolluri VRS, Krishna DKS, Das S, Das BS, Reddy GN. Intracranial tumours and blood groups. Eur J Cancer 1991; 27 (02) 221-222
    CrossrefPubMedGoogle Scholar
  • 17 Carter RL, Hitchocock ER, Sato F. Malignant glioma and ABO blood group. BMJ 1964; 1: 122
    CrossrefPubMedGoogle Scholar
  • 18 Garcia JH, Okazaki H, Aronson SM. Blood-group frequencies and astrocytomata. J Neurosurg 1963; 20: 397-399
    CrossrefPubMedGoogle Scholar
  • 19 Nair MK, Varghese C, Swaminathan R. Cancer: Current scenario, intervention strategies and projections for 2015. NCHM Background papers-Burden of Disease in India. 2005: 219-225
    Google Scholar
  • 20 Yeole BB. Trends in the brain cancer incidence in India. Asian Pac J Cancer Prev 2008; 9 (02) 267-270
    PubMedGoogle Scholar
  • 21 Patidar GK, Dhiman Y. Distribution of ABO and Rh (D) Blood groups in India: a systematic review. ISBT Sci Ser 2020; 16: 37-48
    CrossrefPubMedGoogle Scholar
  • 22 Biegel JA. Cytogenetics and molecular genetics of childhood brain tumors. Neuro-oncol 1999; 1 (02) 139-151
    CrossrefPubMedGoogle Scholar
  • 23 Warren C, James LA, Ramsden RT. et al. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 2003; 40 (11) 802-806
    CrossrefPubMedGoogle Scholar
  • 24 Bayani J, Pandita A, Squire JA. Molecular cytogenetic analysis in the study of brain tumors: findings and applications. Neurosurg Focus 2005; 19 (05) E1
    CrossrefPubMedGoogle Scholar
  • 25 Jones NR, Rossi ML, Gregoriou M, Hughes JT. Investigation of the expression of epidermal growth factor receptor and blood group A antigen in 110 human gliomas. Neuropathol Appl Neurobiol 1990; 16 (03) 185-192
    CrossrefPubMedGoogle Scholar
  • 26 Dasgupta A, Gupta T, Jalali R. Indian data on central nervous tumors: a summary of published work. South Asian J Cancer 2016; 5 (03) 147-153
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Lin Z, Yang R, Li K. et al. Establishment of age group classification for risk stratification in glioma patients. BMC Neurol 2020; 20 (01) 310
    CrossrefPubMedGoogle Scholar
  • 28 Chang L, Zhao S, Dan Z. et al. ABO blood group system and risk of brain tumors: a retrospective case–control study in Northeast of China. Translational Surgery. 2018; 3: 49
    CrossrefPubMedGoogle Scholar
  • 29 Campbell AC, Gaisford W, Paterson E, Steward JK. Tumours in children. A survey carried out in the Manchester region. BMJ 1961; 1 (5224): 448-452
    PubMedGoogle Scholar
  • 30 Zampieri P, Meneghini F, Grigoletto F. et al. Risk factors for cerebral glioma in adults: a case-control study in an Italian population. J Neurooncol 1994; 19 (01) 61-67
    CrossrefPubMedGoogle Scholar
  • 31 Allouh MZ, Al Barbarawi MM, Hiasat MY, Al-Qaralleh MA, Ababneh EI. Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours. Blood Transfus 2017; 15 (06) 543-547
    PubMedGoogle Scholar
  • 32 Turowski K, Czochra M. ABO blood groups in glioblastoma multiforme [in Polish]. Neurol Neurochir Pol 1979; 13 (02) 173-176
    PubMedGoogle Scholar
  • 33 Kumarguru BN, Pallavi P, Sunila. Manjunath GV, Vasan TS, Rajalakshmi BR. Histopathological study of central nervous system lesions: emphasizing association of neoplasms with ABO blood groups. J Clin Diagn Res 2017; 11 (04) EC15-EC20
    PubMedGoogle Scholar
  • 34 Cote DJ, Downer MK, Zoltick ES, Smith TR, Stampfer MJ. ABO blood group and risk of glioma. Neuro-oncol 2017; 19 (06) 871-873
    CrossrefPubMedGoogle Scholar
  • 35 Mehrazin M. ABO blood group frequency and brain tumors. Asian Pac J Cancer Prev 2006; 7 (04) 582-584
    PubMedGoogle Scholar
  • 36 Aird I, Lee DR, Roberts JA. ABO blood groups and cancer of oesophagus, cancer of pancreas, and pituitary adenoma. BMJ 1960; 1 (5180): 1163-1166
    CrossrefPubMedGoogle Scholar
  • 37 Pearce KM, Yates PO. Blood groups and brain tumours. J Neurol Sci 1965; 2 (05) 434-441
    CrossrefPubMedGoogle Scholar